What kind of immune cell is an NK cell?
When you catch a cold, your body produces antibodies and T cells tailored to that virus. But this customized defense takes several days to build. In the meantime, other cells move first, and NK cells (Natural Killer cells) are among them.
NK cells are lymphocytes produced in the bone marrow, making up about 10–20% of lymphocytes in the blood. They belong to innate immunity because they respond immediately, even to targets they have never encountered, without needing prior training. They find and remove virus-infected cells and cells turning abnormal, and they also release signaling molecules that call other immune cells into action.
NK cells fall into two groups. CD56bright cells, which carry plenty of the CD56 protein on their surface, mainly produce signaling molecules that coordinate the immune response. CD56dim cells, which carry less CD56, make up most NK cells in the blood and handle direct attack.
How do NK cells recognize abnormal cells?
The way NK cells tell healthy cells from abnormal ones is closer to weighing signals on a scale. Their surface carries both activating receptors, which receive signals urging attack, and inhibitory receptors, which receive signals telling them to stand down. The response depends on which side is stronger.
Healthy cells display a self-marker called MHC class I on their surface. When an NK cell’s inhibitory receptors (such as KIR) read this marker, it does not attack. Cells that are infected with a virus or have mutated often show less of this marker, and instead display proteins that appear under stress (such as MICA, MICB, and ULBP). When the activating receptor NKG2D grabs these proteins, the scale tips toward attack.
Once it decides to attack, the NK cell presses up against the target and releases cytotoxic granules. Perforin punches holes in the cell membrane, and granzymes enter through these openings to make the cell destroy itself.
| Component | What it does |
|---|---|
| Activating receptors (e.g. NKG2D) | Read stress signals on abnormal cells and push toward attack |
| Inhibitory receptors (e.g. KIR, NKG2A) | Read the self-markers on healthy cells and hold back attack |
| Perforin | Punches holes in the target cell's membrane |
| Granzymes | Enter through the holes and trigger cell death |
| IFN-γ | Sends signals that activate other immune cells |
How do NK cells change with age?
As we age, the immune system as a whole gradually changes, a process called immunosenescence. NK cells are no exception.
First, their makeup shifts. CD56bright cells, which produce signaling molecules, decrease, while fully differentiated CD56dim cells take up a larger share. Each cell also becomes weaker. NK cells from older people release less perforin at the point of contact with target cells than those from younger people, and their killing capacity has been reported to decline accordingly. Their ability to produce signaling molecules such as IFN-γ also drops.
Age alone does not decide everything, however. Healthy older adults who maintain good physical and cognitive function have been observed to keep the number and function of their NK cells relatively well preserved. This is why lifestyle factors such as exercise and nutrition are often discussed as influences on NK cell health.
What is the relationship between NK cells and senescent cells?
When damage builds up, cells may stop dividing and become senescent cells. This is a safeguard that keeps damaged cells from multiplying, and a normal process that also plays a role in wound healing and tumor suppression.
The problem is that these cells do not disappear easily. Senescent cells stop dividing but stay metabolically active, releasing inflammation-related substances such as IL-6, IL-8, and MMPs into their surroundings. This is called SASP (senescence-associated secretory phenotype). In youth, the immune system clears senescent cells relatively quickly, but with age, clearance slows, they accumulate in tissues, and low-grade chronic inflammation persists. This state is called inflammaging, a blend of inflammation and aging.
NK cells are among the immune cells responsible for this cleanup. Stress proteins also increase on the surface of senescent cells, and experimental studies have confirmed that NK cells recognize them through NKG2D and eliminate the cells. This action of selectively removing senescent cells is called senolytic.
Senescent cells do not simply wait to be removed. Some increase HLA-E, which stimulates NK cells’ inhibitory receptor (NKG2A), to avoid attack, or shed their stress proteins to stay hidden. The current explanation is that senescent cells accumulate when declining NK cell function coincides with these ways of hiding.
Animal studies reporting that genetically removing senescent cells delayed age-related changes have raised interest in ways to reduce senescent cells. Alongside research on senolytic drugs that eliminate senescent cells pharmacologically, approaches that make use of NK cells’ natural clearing function are also being studied.
How far has research on autologous NK cell infusion come?
Autologous NK cell infusion involves separating NK cells from your own blood, expanding and activating them outside the body, and returning them through a vein. In relation to aging, this is still early-stage research, and the human studies published so far are small.
In one study published in 2022, five adults in their 40s to 70s received cultured autologous NK cells, and researchers tracked aging markers (p16 and β-galactosidase) in their blood immune cells. The markers fell two weeks after infusion and rose back toward baseline by around three months, while in the two people who received two infusions, the reduction lasted longer. No adverse reactions were reported during the observation period. However, this was a case study with no control group, funded by the company that conducted it.
Another study published the same year compared 37 healthy middle-aged adults, 32 of whom received autologous NK cells and 5 of whom received saline. Over four weeks after infusion, it reported decreases in the proportion of senescent and exhausted T cells and in some inflammation-related substances. This, too, was a short-term observation of blood markers.
In short, there are early reports that aging markers in the blood change after autologous NK cell infusion, but whether this translates into slower aging or disease prevention has not yet been confirmed. Researchers in the field consistently point out the need for larger controlled studies. TheLINE Plastic Surgery’s NK cell program is also presented based on this state of research.
How do NK cell injections differ from stem cell injections?
Both deliver cells through a vein, but the cells and their purposes differ. NK cells are immune cells that find and remove abnormal cells, while stem cells are involved in tissue recovery and regeneration.
The preparation also differs. NK cells obtained from blood must be cultured for about two weeks at a specialized cell processing facility to increase their numbers. Stem cell IV, by contrast, uses cells obtained from fat or blood that are separated and purified in-clinic on the same day. Because their purposes differ, the two are sometimes planned together, with the order and combination decided based on health status.
What to know before NK cell injections
NK cell injections do not treat disease or reverse aging. It is more accurate to see them as one of several ways to monitor and manage immune health. They are not used to prevent or treat cancer, or as a substitute for existing treatment.
How are NK cells different from T cells?
T cells are adaptive immune cells that learn a specific target and then attack only that target precisely, so their response takes time to build. NK cells are innate immune cells that respond immediately to abnormal signals without prior learning. The two communicate and work together.
Can NK cell status be checked with a test?
There are blood tests that measure the proportion or activity of NK cells. However, a single number cannot describe overall immune status, so results are interpreted together with other tests.
Can lifestyle habits help protect NK cells?
Studies suggest that lifestyle factors such as exercise and nutrition affect NK cell function. However, there is not enough evidence to say that any single food or supplement increases NK cells.
Do NK cell injections prevent cancer?
A study that followed 3,625 people from the general population for 11 years observed fewer cancers among those whose natural NK cell activity was high. However, this study observed the activity of the body's own NK cells and is not evidence that NK cell injections prevent cancer.
How long do the effects last?
In small studies, aging markers in the blood dropped after infusion and then returned toward baseline over several months. For this reason, repeating infusions at set intervals is being studied, and long-term effects have not yet been confirmed.
How does TheLINE's NK cell program work?
After a single blood draw, the cells are cultured and quality-tested for about two weeks at a specialized cell processing facility licensed by the Ministry of Food and Drug Safety, then infused intravenously three times at two-week intervals. Afterward, health status is reassessed every year to decide whether to repeat the program. For the full schedule and process, see our NK cell program page.